Sigue la actividad de operaciones con información privilegiada más reciente de Citius Pharmaceuticals. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Citius Pharmaceuticals.
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
Los expertos no han informado de compras ni ventas en los últimos 30 días.
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Sep 27, 2019 | EXECUTIVE CHAIRMAN | 2.23M | $0.90 | $2.00M | BUY | 27.86% | 10.26M | Sep 27 | ||
Sep 27, 2019 | PRESIDENT AND CEO | 558.60K | $0.90 | $500.00K | BUY | 38.96% | 1.99M | Sep 27 | ||
Apr 05, 2019 | EXECUTIVE CHAIRMAN | 1.17M | $1.54 | $1.80M | BUY | 16.99% | 8.02M | Apr 03 | ||
Apr 05, 2019 | PRESIDENT AND CEO | 129.45K | $1.54 | $200.00K | BUY | 9.93% | 1.43M | Apr 03 | ||
Aug 15, 2018 | EXECUTIVE CHAIRMAN | 3.14M | $1.27 | $4.00M | BUY | 84.37% | 6.86M | Aug 13 | ||
Aug 15, 2018 | PRESIDENT AND CEO | 784.31K | $1.27 | $1.00M | BUY | 150.86% | 1.30M | Aug 13 | ||
Apr 02, 2018 | EXECUTIVE CHAIRMAN | 167.50K | $2.98 | $500.00K | BUY | 4.72% | 3.72M | Mar 29 | ||
Mar 29, 2018 | PRESIDENT AND CEO | 2.92K | $3.09 | $9.01K | BUY | 0.56% | 519.88K | Mar 28 | ||
Jan 08, 2018 | EXECUTIVE CHAIRMAN | 213.11K | $4.69 | $999.47K | BUY | 6.38% | 3.55M | Dec 19 | ||
Aug 28, 2017 | EXECUTIVE CHAIRMAN | 11.00K | $2.68 | $29.48K | BUY | 0.33% | 3.34M | Aug 24 | ||
Aug 10, 2017 | EXECUTIVE CHAIRMAN | 1.97M | $3.31 | $6.52M | BUY | 144.93% | 3.33M | Aug 08 | ||
Apr 12, 2016 | — | 20.12M | $0.60 | $3.00M | BUY | ∞ | 20.12M | Mar 30 |
Explora operaciones con información privilegiada sobre todos los valores.